Increased expression of vascular endothelial growth factor in cyclosporin A-induced gingival overgrowth in rats

Journal of Periodontology

Volumn 77, Issue 1, 2006, Pages 54-60

  Cetinkaya, Burcu Ozkan ^a   Acikgoz, Gokhan ^a   Ayas, Bulent ^a   Aliyev, Eldar ^a   Sakallioglu, Elif Eser ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Agiogenesis; Cyclosporin A; Gingival overgrowth; Vascular endothelial growth factor

Indexed keywords

CYCLOSPORIN A; VASCULOTROPIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD VESSEL DIAMETER; DECAPITATION; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; GINGIVA OVERGROWTH; MALE; MANDIBLE; MICROSCOPY; MORPHOMETRICS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RAT; SOFT TISSUE; STATISTICAL SIGNIFICANCE; ANIMAL; BLOOD VESSEL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONNECTIVE TISSUE; DRUG EFFECT; EPITHELIUM; GINGIVA; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; BLOOD VESSELS; CONNECTIVE TISSUE; CYCLOSPORINE; EPITHELIUM; GINGIVA; GINGIVAL OVERGROWTH; IMMUNOSUPPRESSIVE AGENTS; MALE; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; RATS; RATS, WISTAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646199031     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.77.1.54     Document Type: Article

References (45)

1. Laupacis A, Keown PA, Ulan RA, McKenzie N, Stiller CR. Cyclosporin A: A powerful immunosuppressant. Can Med Assoc J 1982;126:1041-1046.
2. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol 1992;19:1-11.
3. Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A. Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 1984;38:34-37.
4. Bartold PM. Cyclosporine and gingival overgrowth. J Oral Pathol 1987;16:463-468.
5. Mackenzie IC, Hill MW. Connective tissue influences on patterns of epithelial architecture and keratinization in skin and oral mucosa of the adult mouse. Cell Tissue Res 1984;235:551-559.
6. Rostock MH, Fry HR, Turner JE. Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 1986;57:294-299.
7. Niimi A, Tohnai I, Kaneda T, Takeuchi M, Nagura H. Immunohistochemical analysis of effects of cyclosporin A on gingival epithelium. J Oral Pathol Med 1990; 19:397-403.
8. Ayanoglou CM, Lesty C. Cyclosporin A-induced gingival overgrowth in the rat: A histological, ultrastructural and histomorphometric evaluation. J Periodontal Res 1999;34:7-15.
9. Wondimu B, Reinholt FP, Modeer T. Stereologic study of cyclosporin A-induced gingival overgrowth in renal transplant patients. Eur J Oral Sci 1995;103: 199-206.
10. Nurmenniemi PK, Pernu HE, Knuuttila ML. Mitotic activity of keratinocytes in nifedipine- and immuno-suppressive medication-induced gingival overgrowth. J Periodontol 2001;72:167-173.
11. Das SJ, Parkar MH, Olsen I. Upregulation of keratinocyte growth factor in cyclosporin A-induced gingival overgrowth. J Periodontol 2001;72:745-752.
12. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993;90:8915-8919.
13. Iacopino AM, Doxey D, Cutler CW, et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: Possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997;68:73-83.
14. Boltchi FE, Rees TD, Iacopino AM. Cyclosporine A-induced gingival overgrowth: A comprehensive review. Quintessence Int 1999;30:775-783.
15. Saito K, Mori S, Iwakura M, Sakamoto S. Immunohistochemical localization of transforming growth factor beta, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontal Res 1996;31:545-555.
16. Markopoulos AK, Belazi M, Drakoulakos D, et al. Epidermal growth factor in saliva and serum of patients with cyclosporin-induced gingival overgrowth. J Periodontal Res 2001;36:88-91.
17. Koh JT, Kim OJ, Park YS, et al. Decreased expressions of thrombospondin 2 in cyclosporin A-induced gingival overgrowth. J Periodontal Res 2004;39: 93-100.
18. Shihab FS, Bennett WM, Yi H, Andoh TF. Expression of vascular endothelial growth factor and its receptors Flt-1 and KDR/Flk-1 in chronic cyclosporine nephrotoxicity. Transplantation 2001;72:164-168.
19. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362: 841-844.
20. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
21. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
22. Hernandez GL, Volpert OV, Iniguez MA, et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: Roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 2001;193:607-620.
23. Booth V, Young S, Cruchley A, Taichman NS, Paleolog E. Vascular endothelial growth factor in human periodontal disease. J Periodontal Res 1998; 33:491-499.
24. Clauss M. Molecular biology of the VEGF and the VEGF receptor family. Semin Thromb Hemost 2000; 26:561-569.
25. H2-mediated sensitization and inflammation in the lung. Nat Med 2004;10:1095-1103.
26. Ribatti D, Vacca A, Cantatore FP, et al. An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis. Inflamm Res 2000;49:418-423.
27. Esposito C, Fornoni A, Cornacchia F, et al. Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney Int 2000;58:123-130.
28. Wassef R, Cohen Z, Langer B. Pharmacokinetic profiles of cyclosporine in rats: Influence of route of administration and dosage. Transplantation 1985;40: 489-493.
29. Lindhe J, Karring T. The anatomy of periodontium. In: Lindhe J, ed. Textbook of Clinical Periodontology. Copenhagen: Munksgaard; 1993:19-69.
30. Listgarten MA. Similarity of epithelial relationships in the gingiva of rat and man. J Periodontol 1975;46: 677-680.
31. Adams D, Davies G. Gingival hyperplasia associated with cyclosporin A: A report of two cases. Br Dent J 1984;157:89-90.
32. TyIdesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
33. Seibel W, Yahia NA, McCleary LB, Lesko LJ, Hassell TM. Cyclosporine-induced gingival overgrowth in beagle dogs. J Oral Pathol Med 1989;18:240-245.
34. Fu E, Nieh S, Chang HL, Wang SL. Cyclosporin A-induced gingival overgrowth in rats: Macroscopic and microscopic observations. Int J Periodontics Restorative Dent 1996;16:278-291.
35. Kataoka M, Shimizu Y, Kunikiyo K, et al. Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth. J Cell Physiol 2000;182:351-358.
36. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 1996; 149:293-305.
37. Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84: 1470-1478.
38. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci 2000;24(Suppl. 1): S78-84.
39. Yuan K, Jin YT, Lin MT. The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry. J Periodontol 2000; 71:701-709.
40. Friskopp J, Klintmalm G. Gingival enlargement: A comparison between cyclosporine and azathioprine treated renal allograft recipients. Swed Dent J 1986; 10:85-92.
41. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: Old problem, new problem. Crit Rev Oral Biol Med 1991;2:103-137.
42. Hefti AF, Eshenaur AE, Hassell TM, Stone C. Gingival overgrowth in cyclosporine A treated multiple sclerosis patients. J Periodontol 1994;65:744-749.
43. Kantarci A, Cebeci I, Tuncer O, Carin M, Firatli E. Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. J Periodontol 1999;70:587-593.
44. Johnson RB, Serio FG, Dai X. Vascular endothelial growth factors and progression of periodontal diseased. J Periodontol 1999;70:848-852.
45. Williamson MS, Miller EK, Plemons J, Rees TD, Iacopino AM. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: Possible mechanism for gingival overgrowth. J Periodontol 1994;65: 895-903.